ppp1r3b Antibody

What is PPP1R3B and why is it significant in metabolic research?

PPP1R3B (Protein Phosphatase 1 Regulatory Subunit 3B) functions as a glycogen-targeting subunit for phosphatase PP1, facilitating interaction between PP1 and enzymes involved in glycogen metabolism. Its physiological role includes suppressing the rate at which PP1 dephosphorylates (inactivates) glycogen phosphorylase while enhancing the rate at which it activates glycogen synthase, effectively limiting glycogen breakdown . Research has demonstrated that PPP1R3B plays a major role in regulating hepatic glycogen stores and whole-body glucose/energy homeostasis . Irregularities in PPP1R3B functionality have been connected to conditions like type 2 diabetes and glycogen storage disease, making it an important target for metabolic research .

Which experimental applications are most suitable for PPP1R3B antibodies?

Most commercially available PPP1R3B antibodies have been validated for multiple applications:

For optimal results, it's advisable to validate each antibody for your specific experimental conditions and sample types, as reactivity can vary between manufacturers.

How should reactivity be considered when selecting a PPP1R3B antibody?

When selecting a PPP1R3B antibody, species reactivity is a critical factor that must be matched to your experimental model. Based on the available data:

• Human reactivity: Most commercially available antibodies have been validated for human samples

• Mouse reactivity: Several antibodies demonstrate cross-reactivity with mouse samples

• Rat reactivity: Limited options available with confirmed reactivity

• Other species: Some antibodies show cross-reactivity with guinea pig, horse, rabbit, and monkey samples, but these require additional validation

It's essential to verify reactivity claims with the manufacturer and review validation data specifically for your experimental model and application. Non-specific binding can be particularly problematic in less commonly tested species.

What are the optimal sample preparation methods for PPP1R3B detection?

For Western blotting applications:

• Liver tissue represents an optimal sample source due to high PPP1R3B expression levels

• Cell lines with validated expression include MDA-MB-453s cells

• Expected molecular weight is approximately 33 kDa

For immunohistochemistry applications:

• Antigen retrieval is critical; two effective approaches include:

  • TE buffer at pH 9.0 (primary recommendation)

  • Citrate buffer at pH 6.0 (alternative approach)

• Human samples with validated detection include stomach cancer tissue and intrahepatic cholangiocarcinoma tissue

When preparing samples, consider that PPP1R3B is primarily expressed in liver and involved in glycogen metabolism, making liver tissue and hepatocyte-derived samples particularly valuable for experimental validation.

How should antibody specificity for PPP1R3B be validated?

A multi-step validation approach is recommended:

• Epitope verification: Confirm the specific region of PPP1R3B targeted by the antibody. Different antibodies target various regions:

  • C-terminal regions (e.g., AA 205-231)

  • N-terminal regions

  • Full-length protein (AA 1-285)

  • Specific internal fragments (e.g., AA 40-89)

• Positive controls: Verify detection in tissues/cells known to express PPP1R3B:

  • Mouse liver tissue

  • Mouse heart tissue

  • MDA-MB-453s cells

• Cross-reactivity testing: Some manufacturers validate specificity on protein arrays containing the target protein plus 383 other non-specific proteins

• Genetic validation: When possible, validate using:

  • PPP1R3B knockout models

  • PPP1R3B overexpression systems

  • siRNA knockdown approaches

The most conclusive validation involves comparing detection in matched wild-type and PPP1R3B-deficient samples to confirm specificity.

What dilution optimization strategies are recommended for PPP1R3B antibodies?

Dilution optimization is critical for maximizing signal-to-noise ratio. From the provided data, recommended dilution ranges vary significantly by application:

A systematic approach to dilution optimization includes:

• Perform an initial experiment using 3-4 different dilutions spanning the recommended range

• Evaluate both signal intensity and background levels

• Select the dilution that provides maximum specific signal with minimal background

• Document optimal conditions for reproducibility

Many manufacturers emphasize that "it is recommended that this reagent should be titrated in each testing system to obtain optimal results" , highlighting the importance of system-specific optimization.

What storage conditions maximize PPP1R3B antibody stability and performance?

Based on manufacturer recommendations, optimal storage conditions include:

• Short-term storage (weeks): 4°C

• Long-term storage (months to years): -20°C

• Buffer composition: Typically PBS (pH 7.2) with 40-50% glycerol and 0.02% sodium azide

• Handling recommendations:

  • Avoid repeated freeze-thaw cycles

  • Aliquot antibodies for long-term storage

  • Some smaller volume preparations (20μl) may contain 0.1% BSA as a stabilizer

Proper storage significantly impacts antibody performance, with degradation potentially resulting in increased background, reduced specificity, and diminished signal intensity.

How can PPP1R3B antibodies be utilized in studies of mutated PPP1R3B proteins?

Research has identified mutated PPP1R3B as a target in cancer immunotherapy contexts. In one significant study, researchers identified a mutated PPP1R3B epitope as the immunodominant epitope recognized by tumor-reactive T cells in a complete responder patient following adoptive tumor-infiltrating lymphocyte (TIL) therapy .

When designing experiments to detect mutated forms of PPP1R3B:

• Mutation-specific approaches:

  • Consider generating custom antibodies against known mutations

  • The literature documents a C to A transversion at 527 bp resulting in a histidine substitution for proline at position 176

• Validation strategies:

  • Sequence verification of PPP1R3B in your experimental system

  • Comparison of antibody reactivity between wild-type and mutant forms

  • Use of recombinant proteins with defined mutations as controls

• Application considerations:

  • Western blotting may not distinguish mutations that don't affect protein size

  • Mass spectrometry approaches may be necessary to confirm specific mutations

  • Immunoprecipitation followed by sequencing can provide definitive identification

This application represents an advanced use of PPP1R3B antibodies that extends beyond standard protein detection into mutation-specific investigations.

What are the methodology considerations for studying PPP1R3B in glycogen metabolism pathways?

When investigating PPP1R3B's role in glycogen metabolism, several methodological approaches should be considered:

• Functional context: PPP1R3B acts as a glycogen-targeting subunit for phosphatase PP1, regulating glycogen synthesis and breakdown . Design experiments that assess:

  • Glycogen content (biochemical assays)

  • Enzymatic activities of glycogen synthase and phosphorylase

  • Phosphorylation states of glycogen metabolism enzymes

• Interaction studies: PPP1R3B facilitates interaction between PP1 and glycogen metabolism enzymes . Consider:

  • Co-immunoprecipitation with PP1 catalytic subunits

  • Proximity ligation assays for in situ interaction detection

  • Mass spectrometry analysis of PPP1R3B-associated protein complexes

• Physiological contexts: Studies with liver-specific PPP1R3B knockout mice revealed :

  • Significantly reduced glycogen synthase protein abundance

  • Predominance of phosphorylated (inactive) glycogen synthase

  • Impaired glucose incorporation into hepatic glycogen

  • Substantial decrease in total hepatic glycogen content

  • Hypoglycemia susceptibility upon fasting

• Compensatory mechanism detection: Monitor expression of related regulatory subunits (PPP1R3A and PPP1R3C) and rate-limiting enzymes in glycogen metabolism (GYS2 and PYGL) when manipulating PPP1R3B expression .

When designing experiments to investigate these processes, western blotting with PPP1R3B antibodies represents just one component of a comprehensive approach to understanding the protein's functional role in glycogen metabolism pathways.

How should researchers interpret contradictory results between different PPP1R3B antibodies?

When faced with conflicting results using different PPP1R3B antibodies, implement this systematic troubleshooting approach:

• Compare epitope targets:

  • Different antibodies recognize distinct regions of PPP1R3B

  • C-terminal vs. N-terminal targeting may reveal different biological contexts or post-translational modifications

  • Some antibodies target specific domains that might be masked in certain protein complexes

• Evaluate validation rigor:

  • Review specificity validation methods for each antibody

  • Consider antibodies validated on protein arrays or with genetic approaches

  • Assess the breadth of applications and samples validated

• Consider biological variables:

  • PPP1R3B exists in multiple transcript variants that encode the same protein

  • Phosphorylation status may affect epitope accessibility

  • Protein-protein interactions might mask certain epitopes

• Confirmation strategies:

  • Use orthogonal detection methods (e.g., mass spectrometry)

  • Employ genetic approaches (siRNA, CRISPR) to validate antibody specificity

  • Test multiple antibodies targeting different epitopes on the same samples

• Technical considerations:

  • Optimize protocols specifically for each antibody

  • Assess batch-to-batch variation

  • Evaluate fixation and preparation effects on epitope availability

Contradictory results often reflect biological complexity rather than technical failure, potentially revealing important insights about protein conformation, modification, or interactions.

What research applications can benefit from PPP1R3B antibody usage beyond standard protein detection?

PPP1R3B antibodies enable numerous advanced research applications beyond basic protein detection:

• Metabolic disorder research:

  • Investigation of type 2 diabetes mechanisms through PPP1R3B's role in glycogen metabolism

  • Study of glycogen storage diseases and associated liver pathologies

  • Analysis of compensatory mechanisms in glucose homeostasis under metabolic stress

• Cancer immunology investigations:

  • Detection of mutated PPP1R3B as a tumor neoantigen

  • Studies of PPP1R3B expression in various cancer types, including stomach cancer and intrahepatic cholangiocarcinoma

  • Exploration of metabolic reprogramming in cancer cells through glycogen metabolism alterations

• Regulatory network analysis:

  • Mapping of phosphatase regulatory networks using PPP1R3B as an entry point

  • Investigation of insulin signaling effects on PPP1R3B function

  • Analysis of temporal dynamics in metabolic enzyme complex formation

• Tissue-specific metabolism studies:

  • Comparative analysis of PPP1R3B function across different tissues

  • Investigation of liver-specific metabolic pathways

  • Analysis of tissue-specific glycogen metabolism regulation

What antigen retrieval methods are most effective for PPP1R3B detection in FFPE tissues?

Based on manufacturer protocols and validation data, two primary antigen retrieval methods have demonstrated effectiveness for PPP1R3B detection in formalin-fixed paraffin-embedded (FFPE) tissues:

• TE buffer at pH 9.0 (recommended as primary approach)

  • Higher pH can more effectively break formalin-induced protein crosslinks

  • Particularly effective for nuclear and membrane-associated proteins

  • Often produces stronger signal intensity for PPP1R3B detection

• Citrate buffer at pH 6.0 (effective alternative)

  • More gentle approach that may preserve tissue morphology better

  • Widely used standard that may allow for better comparison across studies

  • May be preferable for multiplexed IHC approaches

Additional optimization considerations include:

• Retrieval time: Typically 15-20 minutes, though this may require optimization

• Heat source: Pressure cooker methods often provide more consistent results than microwave-based approaches

• Cooling period: Allowing slides to cool slowly in retrieval solution before further processing

• Sample-specific considerations: Different tissue sources may require adjusted protocols

For tissues with high endogenous phosphatase activity, additional blocking steps may be necessary to reduce background when using phosphatase-based detection systems.

How can PPP1R3B antibodies be integrated into multi-parameter analyses of glycogen metabolism?

For comprehensive analysis of glycogen metabolism pathways, PPP1R3B antibodies can be integrated into multi-parameter experimental designs:

• Multiplex immunofluorescence approaches:

  • Combine PPP1R3B detection with other glycogen metabolism proteins (GYS2, PYGL)

  • Include markers for subcellular localization to track PPP1R3B translocation

  • Incorporate phospho-specific antibodies to correlate PPP1R3B with enzyme activation states

• Correlation with functional readouts:

  • Parallel assays for glycogen content quantification

  • Analysis of glucose incorporation rates into glycogen

  • Measurement of glycogen synthase and phosphorylase activities

• Integration with genomic/transcriptomic data:

  • Correlation of PPP1R3B protein levels with transcript expression

  • Analysis of genetic variants affecting PPP1R3B function

  • Assessment of compensatory gene expression (e.g., PPP1R3A, PPP1R3C)

• Model system considerations:

  • Studies in liver-specific PPP1R3B knockout mice have revealed:

    • Near-complete absence of hepatic glycogen in fed state

    • Hypoglycemia susceptibility during fasting

    • Enhanced gluconeogenesis as a compensatory mechanism

    • Altered expression of glycolytic and gluconeogenic genes

When designing these integrated approaches, careful consideration of sample preparation compatibility across different assay platforms is essential to enable meaningful correlations between protein expression and functional outcomes.